Prognostic role of HPV infection in esophageal squamous cell carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic role of HPV infection in esophageal squamous cell carcinoma
Authors
Keywords
Human papillomavirus, Esophageal squamous cell carcinoma, Neoadjuvant therapy, Heat shock protein, Growth hormone-releasing hormone receptor
Journal
Infectious Agents and Cancer
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-11-29
DOI
10.1186/s13027-018-0210-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis
- (2018) Kelvin K. W. Chan et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis
- (2018) Hai-Feng Ma et al. OncoTargets and Therapy
- The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation—further evidence of the presence of a GHRH pathway in these tumors
- (2017) Bence Kővári et al. HUMAN PATHOLOGY
- HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosis
- (2017) Xiaoxiao Song et al. ONCOLOGY REPORTS
- Overexpressed HSPA2 correlates with tumor angiogenesis and unfavorable prognosis in pancreatic carcinoma
- (2017) Lu-Lu Zhai et al. PANCREATOLOGY
- GHRH Receptor Expression in Malignant Mixed Müllerian Tumors
- (2016) Nicholas Mackrides et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Human papillomavirus-related esophageal cancer survival
- (2016) Lanwei Guo et al. MEDICINE
- p16 Expression as a Surrogate Marker for HPV Infection in Esophageal Squamous Cell Carcinoma can Predict Response to Neo-Adjuvant Chemotherapy
- (2015) Rajeev Kumar et al. Asian Pacific Journal of Cancer Prevention
- The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers
- (2015) Wen-Lun Wang et al. Journal of Digestive Diseases
- Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis
- (2014) J L Petrick et al. BRITISH JOURNAL OF CANCER
- HPV Infection in Esophageal Squamous Cell Carcinoma and Its Relationship to the Prognosis of Patients in Northern China
- (2014) Fangli Cao et al. TheScientificWorldJOURNAL
- Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer
- (2013) X. Li et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Human papillomavirus types 16 and 18 in esophagus squamous cell carcinoma: a meta-analysis
- (2013) Fang Yong et al. ANNALS OF EPIDEMIOLOGY
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- A Patient-Centered Approach to Counseling Patients With Head and Neck Cancer Undergoing Human Papillomavirus Testing: A Clinician's Guide
- (2013) A. Chu et al. ONCOLOGIST
- Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer
- (2011) Robert Farkas et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma
- (2010) A. Antonsson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemo-radiotherapy in Locally Advanced Squamous Cell Oesophageal Cancer—are Upper Third Tumours more Responsive?
- (2009) Andras Papp et al. PATHOLOGY & ONCOLOGY RESEARCH
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- (2008) C. Fakhry et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started